Literature DB >> 12096177

One-year rehospitalization rates of patients discharged on atypical versus conventional antipsychotics.

Nick C Patel1, Peter G Dorson, Nancy Edwards, Stacy Mendelson, M Lynn Crismon.   

Abstract

This study examined one-year rehospitalization rates for patients who were discharged from Austin State Hospital between August 1, 1997, and July 31, 1998, while taking olanzapine, risperidone, or a conventional antipsychotic. Time to readmission was measured by the product-limit formula. Although conventional antipsychotics were associated with a lower rehospitalization rate, no significant difference in the one-year rehospitalization rate was observed between the groups. At 180 days after initial discharge, the patients who received olanzapine had a higher rate of rehospitalization than patients who were taking conventional antipsychotics. Conventional antipsychotics were associated with a lower one-year rehospitalization rate than risperidone or olanzapine.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12096177     DOI: 10.1176/appi.ps.53.7.891

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  5 in total

1.  Rehospitalization rates of patients with bipolar disorder discharged on a mood stabilizer versus a mood stabilizer plus an atypical or typical antipsychotic.

Authors:  Nick C Patel; M Lynn Crismon; Michael Pondrom
Journal:  J Behav Health Serv Res       Date:  2005 Oct-Dec       Impact factor: 1.505

2.  Two-year rehospitalization rates of patients with newly diagnosed or chronic schizophrenia on atypical or typical antipsychotic drugs: retrospective cohort study.

Authors:  Miroslav Herceg; Vlado Jukić; Domagoj Vidović; Viktorija Erdeljić; Ivan Celić; Oliver Kozumplik; Dario Bagarić; Maja Silobrcić Radić
Journal:  Croat Med J       Date:  2008-04       Impact factor: 1.351

3.  Adherence to medication for the treatment of psychosis: rates and risk factors in an Ethiopian population.

Authors:  Menna Alene; Michael D Wiese; Mulugeta T Angamo; Beata V Bajorek; Elias A Yesuf; Nasir Tajure Wabe
Journal:  BMC Clin Pharmacol       Date:  2012-06-18

4.  Outpatient antipsychotic treatment and inpatient costs of schizophrenia.

Authors:  Steven C Marcus; Mark Olfson
Journal:  Schizophr Bull       Date:  2007-06-19       Impact factor: 9.306

5.  A comparison of olanzapine and risperidone on the risk of psychiatric hospitalization in the naturalistic treatment of patients with schizophrenia.

Authors:  Haya Ascher-Svanum; Baojin Zhu; Douglas Faries; Frank R Ernst
Journal:  Ann Gen Hosp Psychiatry       Date:  2004-06-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.